文献速递神经免疫

抗NMDA受体IgG、IgA和IgM抗体的临床和致病意义

Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.
PubMed 文献 · Neurology · 2018-03-16

该研究评估了300例抗NMDAR脑炎、卒中、痴呆、精神分裂症或血清阴性自身免疫性脑炎患者血清中IgG、IgA和IgM型NMDAR抗体,并回顾性分析了1147例IgG NMDAR抗体阳性患者的临床诊断。结果显示IgG NMDAR抗体仅见于抗NMDAR脑炎且均与脑组织和活神经元反应,而IgA或IgM抗体在多种疾病中非特异性地低频率出现且不改变受体水平。

要点

  • IgG NMDAR抗体仅见于抗NMDAR脑炎患者,且所有抗体均与脑组织和活神经元反应。
  • IgA或IgM NMDAR抗体在多种疾病中非特异性地出现(7%),仅少数与脑组织(3%)或活神经元(2%)反应。
  • 在培养神经元中,IgG而非IgA或IgM抗体导致突触和突触外NMDAR减少。

核心结论

  • IgG NMDAR抗体对 anti-NMDAR 脑炎具有高度特异性,并导致NMDAR水平降低。
  • 相比之下,IgA或IgM抗体在其他疾病中不常见且非特异性出现,并且不改变受体水平。

研究设计与样本

  • 评估300例抗NMDAR脑炎、卒中、痴呆、精神分裂症或血清阴性自身免疫性脑炎患者血清中的IgG、IgA和IgM NMDAR抗体,采用细胞学检测和脑组织及活神经元免疫染色检查抗体及其对培养神经元的影响。
  • 回顾性分析自2005年以来识别的1147例IgG NMDAR抗体阳性患者的临床诊断。

主要发现

  • 在研究的300例患者中,IgG NMDAR抗体仅见于抗NMDAR脑炎患者,且所有抗体均与脑组织和活神经元反应。
  • 通过细胞学检测,300例患者中22例(7%)检测到IgA或IgM抗体,分布于不同疾病,但仅10例(3%)与脑组织反应,7例(2%)与活神经元反应。
  • 在培养神经元中,IgG而非IgA或IgM抗体导致突触和突触外NMDAR减少。
  • 在1147例IgG NMDAR抗体阳性患者队列中,1015例(88.5%)为抗NMDAR脑炎,45例(3.9%)为疾病局限型,41例(3.6%)为自身免疫性单纯疱疹后脑炎,37例(3.2%)为重叠综合征(抗NMDAR脑炎和脱髓鞘疾病),9例(0.8%)为非典型脑炎综合征;无一例精神分裂症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the frequency and clinical relevance of immunoglobulin (Ig)G, IgA, and IgM N-methyl-d-aspartate receptor (NMDAR) antibodies in several diseases, and whether the IgG antibodies occur in disorders other than anti-NMDAR encephalitis. METHODS: Evaluation of IgG, IgA, and IgM NMDAR antibodies in serum of 300 patients with anti-NMDAR encephalitis, stroke, dementia, schizophrenia, or seronegative autoimmune encephalitis. Antibodies and their effect on cultured neurons were examined with cell-based assays and brain and live neuronal immunostaining. Retrospective analysis of the clinical diagnoses of a cohort of 1,147 patients with IgG NMDAR antibodies identified since 2005. RESULTS: Among the 300 patients studied, IgG NMDAR antibodies were only identified in those with anti-NMDAR encephalitis and all reacted with brain and live neurons. By cell-based assay, IgA or IgM antibodies were detected in 22 of 300 patients (7%) with different diseases, but only 10 (3%) reacted with brain and 7 (2%) with live neurons. In cultured neurons, IgG but not IgA or IgM antibodies caused a decrease of synaptic and extrasynaptic NMDAR. Among the cohort of 1,147 patients with IgG NMDAR antibodies, 1,015 (88.5%) had anti-NMDAR encephalitis, 45 (3.9%) a limited form of the disease, 41 (3.6%) autoimmune post-herpes simplex encephalitis, 37 (3.2%) overlapping syndromes (anti-NMDAR encephalitis and demyelinating disease), and 9 (0.8%) atypical encephalitic syndromes; none had schizophrenia. CONCLUSIONS: IgG NMDAR antibodies are highly specific for anti-NMDAR encephalitis and cause a decrease of the levels of NMDAR. In contrast, IgA or IgM antibodies occur infrequently and nonspecifically in other diseases and do not alter the receptor levels.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Hara M, Martinez-Hernandez E, Ariño H, et al. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor. Neurology. 2018. PMID: 29549218. doi:10.1212/WNL.0000000000005329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。